24. Saxe DF, Boggs SS, Boggs DR: Transplantation of chromosomally marked syngeneic marrow 
cells into mice not subjected to hematopoietic stem cell depletion. Exp Hematol 12:277, 1984. 
25. Wu DD, Keating A: Hematopoietic stem cells engraft in untreated transplant recipients. Exp 
Hematology 21:251-256, 1993. 
26. Stewart FM, Crittenden RB, Williams ME, Pearson-White S, Quesenberry PJ: Long-term 
engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated 
mice. Blood 81:2566-2571, 1993. 
27. Carter RF, Abrams-Ogg CC, Dick JE, Druth SA, Valli VE, Kamel-Reid S, Dube ID: Autologous, 
transplantation of canine long-term marrow culture cells genetically marked by retroviral vectors.. 
Blood 79:356-364, 1992. 
28. Miller AD, Garcia JV, vonSuhr N, Lynch CM, Wilson C, Eiden MV: Construction and 
properties of retrovirus packaging cells based on gibbon ape leukemia virus. J Virol 65:2220- 
2224, 1991. 
i 
29. Miller AD, Rosman GJ: Improved retroviral vectors for gene transfer and expression. 
BioTechniques 7:980-990, 1989. 
30. Rosenberg SA, Aebersold P, Cornetta K, Kasid A, Morgan RA, Moen R, Karson EM, Lotze 
MT, Yang JC, Topalian SL, Merino MJ, Culver K, Miller AD, Blaese RM, Anderson WF: Gene 
transfer into humans - immunotherapy of patients with advanced melanoma, using tumor- 
infiltrating lymphocytes modified by retroviral gene transduction. N Engl J Med 323:570-578, 
1990. 
31. Armentano D, Yu SF, Kantoff PW, von Ruden T, Anderson WF, Gilboa E: Effect of internal 
viral sequences on the utility of retroviral vectors. J Virol 61:1647-1650, 1987. 
32. Miller AD, Law MF, Verma IM: Generation of helper-free amphotropic retroviruses that 
transduce a dominant-acting, methotrexate-resistant dihydrofolate reductase gene. Mol Cell Biol 
5:431-437, 1985. 
33. Deeg HJ, Prentice R, Fritz TE, Sale GE, Lombard LS, Thomas ED, Storb R: Increased 
incidence of malignant tumors in dogs after total body irradiation and marrow transplantation. 
Int J Radiat Oncol Biol Phys 9:1505-1511, 1983. 
34. Kolb HJ, Guenther W, Duell T Socie G, Schaeffer E, Holler E, Schumm M, Horowitz MM, 
Gale RP, Fliedner TM: Cancer after bone marrow transplantation. Bone Marrow 
Transplantation 10(Suppl. 1): 135-138, 1992. 
35. Broerse JJ, Hollander CF, Van Zwieten MJ: Tumor induction in Rhesus monkeys after total 
body irradiation with x-rays and fission neutrons. Int J Radiat Biol 40:671-676, 1981. 
36. Witherspoon RP, Fisher LD, Schoch G, Martin P, Sullivan KM, Sanders J, Deeg HJ, Doney K, 
Thomas D, Storb R, Thomas ED: Secondary cancers after bone marrow transplantation for 
leukemia or aplastic anemia. N Engl J Med 321:784-789, 1989. 
37. Cornetta K, Moen RC, Culver K, Morgan RA, McLachlin JR, Sturm S,Selegue J, London W, 
Blaese M, Anderson WF: Amphotropic murine leukemia retrovirus is not an acute pathogen for 
primates. Human Gene Therapy 1:15-30, 1990. 
38. Anderson WF: What about those monkeys that got T-cell lymphoma? Human Gene Therapy 
4:1-2, 1993. 
39. Cornetta K, Morgan RA, Gillio A, Sturm S, Baltrucki L, O’Reilly R, Anderson WF: No 
retroviremia or pathology in long-term follow-up of monkeys exposed to a murine amphotropic 
retrovirus. Human Gene Therapy 2:215-219, 1991. 
40. Donahue RE, Kessler SW, Bodine D, McDonagh K, Dunbar C, Goodman S, Agricola B, Byrne 
E, Raffeld M, Moen R, Bacher J, Zsebo KM, Nienhuis AW, Helper virus induced T cell 
lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med 176:1125- 
1135, 1992. 
1 1 
i'i 
Recombinant DNA Research, Volume 18 
[680] 
